Page 21 - Pharma Companies

Alkem Labs Q1 profit jumps 2-fold to Rs 423.2 cr, revenue up at Rs 2,004 cr

Consolidated revenue from operations of the company stood at Rs 2,003.49 crore for the quarter under consideration. It was Rs 1,849.50 crore for the same period a year ago, it added

CVS raises profit forecast, in talks with US to administer Covid vaccines

CVS also said it was working with laboratories to cut down the turnaround time for coronavirus test results, which had spiked in July due to a massive increase in demand for tests

Teva Pharmaceutical's Q2 profit tops forecast, reaffirms 2020 outlook

The company also released with Regeneron Pharmaceuticals results for advanced trials for pain medication fasinumab

Zenara Pharma receives DCGI approval to manufacture, sell Favipiravir

Zenara Pharma announced that it has received approval from the DCGI to manufacture and sell Favipiravir tablets as a treatment option for patients with mild to moderate symptoms of Covid-19.

Cipla witnesses 3 senior-level exits including India biz CEO Nikhil Chopra

The company's rich legacy of care and strong sense of purpose rooted in a culture of meritocracy and high performance standards have made Cipla an employer of choice for several industry leaders

Sun Pharma posts surprise Rs 2,184 cr Q1 pre-tax loss on one-time expense

Firm's US revenue dips 33.5%; one-time loss of Rs 3,633 cr pertains to $213.3 mn pzayment by Taro, a Sun Pharma subsidiary, for settlement of anti-trust cases in the US

Sun Pharma Q1 net loss at Rs 1,655.6 cr, revenue down to Rs 7,585.3 cr

The company had posted a net profit of Rs 1,387.48 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing

Dr Reddy's Q1 PAT falls 13% to Rs 579 cr, revenue up by 15% to Rs 4,417 cr

Commenting on the results, co-chairman and MD, G V Prasad said "the current quarter's financial performance has been strong across all parameters

Hetero launches generic Covid-19 drug 'Favivir' at Rs 59 per tablet

It improves treatment accessibility to a significant amount of Covid-19 patient population, which have mild to moderate symptoms,Hetero said

Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet

The company hopes that the easy accessibility and affordable price point of an effective treatment such as Favivent will offer Indian citizens a timely, much-needed therapeutic solution

GSK buys 10% stake of German biotech firm CureVac in $164-million deal

GSK and CureVac, backed by Bill Gates, will work on developing up to five so-called mRNA-based vaccines and monoclonal antibodies (mAbs) for infectious diseases, they said.

Why vaccines can't be launched overnight

Under normal circumstances, the development of new vaccines and treatments could take 10-20 years

Covid-19: Moderna soars 18% as vaccine gives promising early results

The US biotech firm's breakthrough is one of the most promising developments yet in the race to develop a vaccine against the virus that has paralysed the world's economy.

Lupin shuts manufacturing plant after 17 staff test Covid-19 positive

The firm has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employees, according to the company website.

Wall Street gains as Gilead data offsets coronavirus fears; Dow leads gains

Gilead's remdesivir significantly improved clinical recovery and reduced the risk of death in Covid-19 patients, additional data from a late-stage study showed.

Remdesivir reduced risk of Covid-19 deaths, but more studies needed: Gilead

The company, which had initially released the data from the trial in April, said the finding requires confirmation in clinical trials

Emergent signs 5-year deal to make drug used in J&J's Covid-19 vaccine

The news follows a $135 million deal struck by the two companies in April, to use Emergent's manufacturing facilities to speed up the development and production of its vaccine candidate

WHO expects results from Covid-19 drug trials within two weeks

Mike Ryan, head of the WHO's emergencies programme, said it would be unwise to predict when a vaccine could be ready against Covid-19

Relief for pharma firms as govt starts clearing API imports from China

This comes after a week of economic disruption caused by introducing stringent scrutiny, resulting in shipments originating in China getting held up at Indian ports.

Shot of Hope: Equal access a hurdle after race to coronavirus vaccine

The second of a two-part series examines challenges linked to IPR and monopoly once Covid-19 vaccine is created